MENU
NEWSLETTERS
MENU
SECTIONS
OTHER
CLASSIFIEDS
CONTACT US / FAQ
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Biofrontera Inc. - Warrants (NQ:BFRIW)

0.0349 UNCHANGED
Streaming Delayed Price Updated: 2:13 PM EDT, Jul 29, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 4
Open 0.0349
Bid (Size) 0.0232 (6,000)
Ask (Size) 0.0350 (400)
Prev. Close 0.0349
Today's Range 0.0349 - 0.0349
52wk Range 0.0201 - 0.1900
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Biofrontera Inc. to Participate in Benchmark’s 11th Annual Discovery One-on-One Investor Conference
From Biofrontera Inc.
Via GlobeNewswire
News headline image
BIOFRONTERA INC. TO PARTICIPATE IN RENMARK’S VIRTUAL NON-DEAL ROADSHOW SERIES ON WEDNESDAY, NOVEMBER 30, MONDAY, DECEMBER 5, FRIDAY, DECEMBER 9, AND MONDAY, DECEMBER 19 2022
From Biofrontera Inc.
Via GlobeNewswire

Performance

YTD
-41.8%
-41.8%
1 Month
+57.2%
+57.2%
3 Month
+20.8%
+20.8%
6 Month
-44.6%
-44.6%
1 Year
-80.6%
-80.6%

More News

Read More
News headline image
Biofrontera to Launch Phase 3 Clinical Study Evaluating Ameluz®-PDT for the Treatment of Actinic Keratosis on the Extremities, Neck and Trunk
From Biofrontera Inc.
Via GlobeNewswire
News headline image
Biofrontera Inc. Reports Third Quarter 2022 Financial Results and Provides a Business Update
From Biofrontera Inc.
Via GlobeNewswire
News headline image
Biofrontera Inc. to Report Third Quarter Financial Results on November 14, 2022
From Biofrontera Inc.
Via GlobeNewswire
News headline image
Biofrontera Inc. Fully Exercises Recently Acquired Options to Purchase Shares of Biofrontera AG
From Biofrontera Inc.
Via GlobeNewswire
News headline image
Biofrontera Inc. Enters into Agreements to Purchase Options of Biofrontera AG
From Biofrontera Inc.
Via GlobeNewswire
News headline image
Biofrontera Inc. Names Fred Leffler as Chief Financial Officer
From Biofrontera Inc.
Via GlobeNewswire
News headline image
Biofrontera Inc. to Present at the LD Micro Main Event XV Investor Conference
From Biofrontera Inc.
Via GlobeNewswire
News headline image
Biofrontera Inc. to Sponsor the 2022 Fall Clinical Dermatology Conference
From Biofrontera Inc.
Via GlobeNewswire
News headline image
Biofrontera Inc. Adopts Limited Duration Shareholder Rights Plan
From Biofrontera Inc.
Via GlobeNewswire
News headline image
BIOFRONTERA INC. TO PARTICIPATE IN RENMARK’S VIRTUAL NON-DEAL ROADSHOW SERIES ON FRIDAY OCTOBER 14, AND TUESDAY OCTOBER 18, 2022
From Biofrontera Inc.
Via GlobeNewswire
News headline image
Biofrontera Inc. Announces Preliminary Product Revenues for the Third Quarter of 2022
From Biofrontera Inc.
Via GlobeNewswire
News headline image
Biofrontera Inc. to Present at the Roth Inaugural Healthcare Opportunities Conference
From Biofrontera Inc.
Via GlobeNewswire
News headline image
Biofrontera Inc. Announces Exercise of Existing Warrants and Issuance of Warrants in Private Placement
From Biofrontera Inc.
Via GlobeNewswire

Frequently Asked Questions

Is Biofrontera Inc. - Warrants publicly traded?
Yes, Biofrontera Inc. - Warrants is publicly traded.
What exchange does Biofrontera Inc. - Warrants trade on?
Biofrontera Inc. - Warrants trades on the Nasdaq Stock Market
What is the ticker symbol for Biofrontera Inc. - Warrants?
The ticker symbol for Biofrontera Inc. - Warrants is BFRIW on the Nasdaq Stock Market
What is the current price of Biofrontera Inc. - Warrants?
The current price of Biofrontera Inc. - Warrants is 0.0349
When was Biofrontera Inc. - Warrants last traded?
The last trade of Biofrontera Inc. - Warrants was at 07/29/26 02:13 PM ET
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story